Benzinga  Aug 12  Comment 
Maxygen, Inc. (Nasdaq: MAXY), today announced that at the company's annual meeting, held earlier today, the shareholders of Maxygen voted to approve the liquidation and dissolution of the company. As contemplated in connection with the approval...
Benzinga  Jun 3  Comment 
Maxygen (Nasdaq: MAXY), a biopharmaceutical company, today announced that its Board of Directors has approved the liquidation and dissolution of the company, subject to shareholder approval, and plans to distribute all available cash to its...
StreetInsider.com  May 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Maxygen+%28MAXY%29+Narrows+Q1+Loss/8302814.html for the full story.
StreetInsider.com  Mar 12  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Maxygen+%28MAXY%29+Narrows+Q4+Loss+to+6cShare/8178593.html for the full story.
StreetInsider.com  Nov 6  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Maxygen+%28MAXY%29+Q3+Loss+Widens+to+10cShare/7849891.html for the full story.
StreetInsider.com  Sep 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Dividends/Maxygen+%28MAXY%29+Q2+EPS+Falls+47%25+to+%240.99%3B+Declares+Special+Dividend/7711120.html for the full story.
Benzinga  Aug 7  Comment 
Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company, today announced financial and business results for the quarter ended June 30, 2012. Maxygen also announced today that its Board of Directors has authorized a special pro rata distribution of...
Benzinga  May 14  Comment 
Maxygen, Inc. (Nasdaq: MAXY) today announced that it will receive a $30.0 million payment from Bayer HealthCare LLC in connection with Bayer's continued clinical development of a recombinant factor VIIa product candidate for the treatment of...
StreetInsider.com  May 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Maxygen+%28MAXY%29+Swings+to+Q1+Loss/7409885.html for the full story.
StreetInsider.com  Oct 10  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Maxygen+%28MAXY%29+Shares+Rise+Amid+Final+Rejection+of+All+Claims+of+Amgen+%27804+Patent/6845091.html for the full story.

You may also be interested in articles related to Maxygen (MAXY):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki